Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-02-10 @ 7:03 PM
Study NCT ID:
NCT02545751
Status:
UNKNOWN
Last Update Posted:
2017-11-28
First Post:
2015-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Sponsor:
Hangzhou Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Hangzhou CH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None